HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Controlled study of 50-Hz repetitive transcranial magnetic stimulation for the treatment of Parkinson disease.

AbstractOBJECTIVE:
To investigate the safety and efficacy of 50-Hz repetitive transcranial magnetic stimulation (rTMS) in the treatment of motor symptoms in Parkinson disease (PD).
BACKGROUND:
Progression of PD is characterized by the emergence of motor deficits that gradually respond less to dopaminergic therapy. rTMS has shown promising results in improving gait, a major cause of disability, and may provide a therapeutic alternative. Prior controlled studies suggest that an increase in stimulation frequency might enhance therapeutic efficacy.
METHODS:
In this randomized, double blind, sham-controlled study, the authors investigated the safety and efficacy of 50-Hz rTMS of the motor cortices in 8 sessions over 2 weeks. Assessment of safety and clinical efficacy over a 1-month period included timed tests of gait and bradykinesia, Unified Parkinson's Disease Rating Scale (UPDRS), and additional clinical, neurophysiological, and neuropsychological parameters. In addition, the safety of 50-Hz rTMS was tested with electromyography-electroencephalogram (EMG-EEG) monitoring during and after stimulation.
RESULTS:
The authors investigated 26 patients with mild to moderate PD: 13 received 50-Hz rTMS and 13 sham stimulation. The 50-Hz rTMS did not improve gait, bradykinesia, and global and motor UPDRS, but there appeared a short-lived "on"-state improvement in activities of daily living (UPDRS II). The 50-Hz rTMS lengthened the cortical silent period, but other neurophysiological and neuropsychological measures remained unchanged. EMG/EEG recorded no pathological increase of cortical excitability or epileptic activity. There were no adverse effects.
CONCLUSION:
It appears that 50-Hz rTMS of the motor cortices is safe, but it fails to improve motor performance and functional status in PD. Prolonged stimulation or other techniques with rTMS might be more efficacious but need to be established in future research.
AuthorsDavid H Benninger, Kazumi Iseki, Sarah Kranick, David A Luckenbaugh, Elise Houdayer, Mark Hallett
JournalNeurorehabilitation and neural repair (Neurorehabil Neural Repair) 2012 Nov-Dec Vol. 26 Issue 9 Pg. 1096-105 ISSN: 1552-6844 [Electronic] United States
PMID22593114 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Double-Blind Method
  • Electroencephalography
  • Electromyography
  • Evoked Potentials, Motor (physiology)
  • Female
  • Follow-Up Studies
  • Gait (physiology)
  • Gait Disorders, Neurologic (etiology, rehabilitation)
  • Humans
  • Hypokinesia (etiology, rehabilitation)
  • Male
  • Middle Aged
  • Motor Cortex (physiology)
  • Movement (physiology)
  • Parkinson Disease (rehabilitation)
  • Rest (physiology)
  • Transcranial Magnetic Stimulation (adverse effects, methods)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: